1. Academic Validation
  2. Rab-interacting lysosomal protein (RILP): the Rab7 effector required for transport to lysosomes

Rab-interacting lysosomal protein (RILP): the Rab7 effector required for transport to lysosomes

  • EMBO J. 2001 Feb 15;20(4):683-93. doi: 10.1093/emboj/20.4.683.
G Cantalupo 1 P Alifano V Roberti C B Bruni C Bucci
Affiliations

Affiliation

  • 1 Dipartimento di Biologia e Patologia Cellulare e Molecolare L.Califano and Centro di Endocrinologia ed Oncologia Sperimentale G.Salvatore del Consiglio Nazionale delle Ricerche, Università degli Studi di Napoli Federico II, Italy.
Abstract

Rab7 is a small GTPase that controls transport to endocytic degradative compartments. Here we report the identification of a novel 45 kDa protein that specifically binds Rab7GTP at its C-terminus. This protein contains a domain comprising two coiled-coil regions typical of myosin-like proteins and is found mainly in the cytosol. We named it RILP (Rab-interacting lysosomal protein) since it can be recruited efficiently on late endosomal and lysosomal membranes by Rab7GTP. RILP-C33 (a truncated form of the protein lacking the N-terminal half) strongly inhibits epidermal growth factor and low-density lipoprotein degradation, and causes dispersion of lysosomes similarly to Rab7 dominant-negative mutants. More importantly, expression of RILP reverses/prevents the effects of Rab7 dominant-negative mutants. All these data are consistent with a model in which RILP represents a downstream effector for Rab7 and both proteins act together in the regulation of late endocytic traffic.

Figures